Aureus Asset Management LLC decreased its holdings in HealthEquity, Inc. (NASDAQ:HQY – Free Report) by 85.6% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 31,670 shares of the company’s stock after selling 187,994 shares during the quarter. Aureus Asset Management LLC’s holdings in HealthEquity were worth $2,647,000 as of its most recent filing with the Securities & Exchange Commission.
Other large investors have also added to or reduced their stakes in the company. Fifth Third Wealth Advisors LLC increased its position in HealthEquity by 4.2% during the 1st quarter. Fifth Third Wealth Advisors LLC now owns 2,872 shares of the company’s stock valued at $240,000 after purchasing an additional 116 shares during the period. Truist Financial Corp lifted its position in shares of HealthEquity by 4.9% in the 4th quarter. Truist Financial Corp now owns 2,537 shares of the company’s stock worth $232,000 after purchasing an additional 119 shares during the period. Fiduciary Trust Co boosted its stake in shares of HealthEquity by 3.4% during the 3rd quarter. Fiduciary Trust Co now owns 3,669 shares of the company’s stock valued at $348,000 after purchasing an additional 120 shares in the last quarter. Larson Financial Group LLC boosted its stake in shares of HealthEquity by 24.4% during the 3rd quarter. Larson Financial Group LLC now owns 628 shares of the company’s stock valued at $60,000 after purchasing an additional 123 shares in the last quarter. Finally, GAMMA Investing LLC increased its position in shares of HealthEquity by 9.5% during the fourth quarter. GAMMA Investing LLC now owns 1,944 shares of the company’s stock valued at $178,000 after buying an additional 168 shares during the period. Institutional investors own 99.55% of the company’s stock.
Insider Transactions at HealthEquity
In other news, EVP Michael Henry Fiore sold 2,354 shares of the firm’s stock in a transaction on Friday, July 10th. The stock was sold at an average price of $95.00, for a total transaction of $223,630.00. Following the completion of the transaction, the executive vice president directly owned 52,244 shares in the company, valued at $4,963,180. This trade represents a 4.31% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Gayle Furgurson Wellborn sold 2,439 shares of HealthEquity stock in a transaction dated Thursday, May 28th. The stock was sold at an average price of $90.00, for a total value of $219,510.00. Following the completion of the transaction, the director directly owned 19,733 shares of the company’s stock, valued at approximately $1,775,970. This represents a 11.00% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Over the last three months, insiders have sold 17,905 shares of company stock valued at $1,651,280. Insiders own 1.60% of the company’s stock.
HealthEquity Stock Performance
HealthEquity (NASDAQ:HQY – Get Free Report) last posted its quarterly earnings data on Thursday, May 28th. The company reported $1.24 earnings per share for the quarter, beating analysts’ consensus estimates of $1.11 by $0.13. The company had revenue of $354.64 million during the quarter, compared to analyst estimates of $352.02 million. HealthEquity had a return on equity of 14.75% and a net margin of 17.25%.The business’s revenue for the quarter was up 7.2% on a year-over-year basis. HealthEquity has set its FY 2027 guidance at 2.880-2.950 EPS. Equities research analysts anticipate that HealthEquity, Inc. will post 3.92 earnings per share for the current fiscal year.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on HQY shares. BMO Capital Markets raised shares of HealthEquity from a “market perform” rating to an “outperform” rating and increased their price target for the stock from $85.00 to $105.00 in a research note on Thursday, April 9th. Barrington Research reiterated an “outperform” rating and set a $110.00 target price on shares of HealthEquity in a report on Friday, May 22nd. Wells Fargo & Company set a $111.00 target price on HealthEquity in a report on Monday, June 1st. Weiss Ratings raised HealthEquity from a “hold (c)” rating to a “hold (c+)” rating in a research report on Friday, June 5th. Finally, Citigroup restated a “market outperform” rating on shares of HealthEquity in a research note on Monday, June 1st. Eleven analysts have rated the stock with a Buy rating, one has issued a Hold rating and one has issued a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and a consensus target price of $110.57.
Read Our Latest Stock Analysis on HQY
HealthEquity Company Profile
HealthEquity, Inc (NASDAQ: HQY) is a leading administrator of consumer-directed health accounts and related benefit solutions in the United States. Founded in 2002 and headquartered in Draper, Utah, the company specializes in health savings accounts (HSAs) and offers complementary services such as flexible spending accounts (FSAs), health reimbursement arrangements (HRAs), COBRA administration and commuter benefits. Through its technology-driven platform, HealthEquity enables employers, health plans and individuals to streamline account management, improve cost transparency and encourage more informed healthcare spending.
Serving millions of members across all 50 states, HealthEquity leverages an open-architecture ecosystem that integrates with health plans, payroll providers and financial institutions.
Read More
- Five stocks we like better than HealthEquity
- Could Truth API Become Trump Media’s First Meaningful Revenue Driver?
- Small Caps Are Crushing the S&P 500—3 Stocks Still Worth Buying
- Moog Is More Than a Missile Maker, and Wall Street Is Noticing
- A Boring Dividend Growth Strategy Becomes a Solid Defensive Play
Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY – Free Report).
Receive News & Ratings for HealthEquity Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HealthEquity and related companies with MarketBeat.com's FREE daily email newsletter.
